LURAP1L
geneOn this page
Also known as MGC46502FLJ38505bA3L8.2LRAP35b
Summary
LURAP1L (leucine rich adaptor protein 1 like, HGNC:31452) is a protein-coding gene on chromosome 9p23, encoding Leucine rich adaptor protein 1-like (Q8IV03).
Predicted to be involved in positive regulation of canonical NF-kappaB signal transduction.
Source: NCBI Gene 286343 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 77 total — 1 likely-pathogenic
- MANE Select transcript:
NM_203403
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31452 |
| Approved symbol | LURAP1L |
| Name | leucine rich adaptor protein 1 like |
| Location | 9p23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC46502, FLJ38505, bA3L8.2, LRAP35b |
| Ensembl gene | ENSG00000153714 |
| Ensembl biotype | protein_coding |
| OMIM | 616130 |
| Entrez | 286343 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000319264, ENST00000489107
RefSeq mRNA: 1 — MANE Select: NM_203403
NM_203403
CCDS: CCDS6473
Canonical transcript exons
ENST00000319264 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001259535 | 12821386 | 12823060 |
| ENSE00001259560 | 12775020 | 12776027 |
Expression profiles
Bgee: expression breadth ubiquitous, 222 present calls, max score 89.62.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.0360 / max 311.9629, expressed in 1233 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 96113 | 13.0470 | 1184 |
| 96112 | 0.7587 | 493 |
| 96114 | 0.2302 | 70 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| islet of Langerhans | UBERON:0000006 | 89.62 | gold quality |
| calcaneal tendon | UBERON:0003701 | 89.59 | gold quality |
| right lung | UBERON:0002167 | 89.34 | gold quality |
| popliteal artery | UBERON:0002250 | 88.68 | gold quality |
| tibial artery | UBERON:0007610 | 88.66 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 87.67 | gold quality |
| upper lobe of lung | UBERON:0008948 | 87.29 | gold quality |
| minor salivary gland | UBERON:0001830 | 86.80 | gold quality |
| aorta | UBERON:0000947 | 86.49 | gold quality |
| adrenal tissue | UBERON:0018303 | 86.17 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.14 | gold quality |
| lung | UBERON:0002048 | 85.76 | gold quality |
| gall bladder | UBERON:0002110 | 85.74 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 85.67 | gold quality |
| left coronary artery | UBERON:0001626 | 85.31 | gold quality |
| right lobe of liver | UBERON:0001114 | 85.17 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 84.98 | gold quality |
| transverse colon | UBERON:0001157 | 84.10 | gold quality |
| pancreas | UBERON:0001264 | 83.94 | gold quality |
| right coronary artery | UBERON:0001625 | 83.92 | gold quality |
| ascending aorta | UBERON:0001496 | 83.87 | gold quality |
| thoracic aorta | UBERON:0001515 | 83.80 | gold quality |
| coronary artery | UBERON:0001621 | 83.66 | gold quality |
| stromal cell of endometrium | CL:0002255 | 83.48 | gold quality |
| colon | UBERON:0001155 | 83.16 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 83.09 | gold quality |
| cerebellar cortex | UBERON:0002129 | 83.02 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 83.01 | gold quality |
| large intestine | UBERON:0000059 | 82.98 | gold quality |
| rectum | UBERON:0001052 | 82.87 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8142 | yes | 41.57 |
| E-HCAD-11 | yes | 23.94 |
| E-ANND-3 | yes | 9.12 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
147 targeting LURAP1L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548Y | 99.94 | 71.28 | 3514 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lurap1l | ENSMUSG00000048706 |
| rattus_norvegicus | Lurap1l | ENSRNOG00000033740 |
Paralogs (1): LURAP1 (ENSG00000171357)
Protein
Protein identifiers
Leucine rich adaptor protein 1-like — Q8IV03 (reviewed: Q8IV03)
All UniProt accessions (1): Q8IV03
UniProt curated annotations — full annotation on UniProt →
Polymorphism. The poly-Gly region is polymorphic and the number of Gly varies in the population (from 9 to 12).
RefSeq proteins (1): NP_981948* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037443 | LURAP1 | Family |
| IPR039499 | LURA1/LRA25 | Family |
Pfam: PF14854
UniProt features (12 total): compositionally biased region 4, sequence variant 3, sequence conflict 2, chain 1, region of interest 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IV03-F1 | 66.08 | 0.24 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 1
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 109 (showing top):
AAGCAAT_MIR137, GCANCTGNY_MYOD_Q6, GOZGIT_ESR1_TARGETS_DN, GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, AP4_Q6, CAGCTG_AP4_Q5, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, SOX9_B1, WANG_LMO4_TARGETS_DN, ENGELMANN_CANCER_PROGENITORS_UP, RIGGI_EWING_SARCOMA_PROGENITOR_DN, TCF11_01, MYOD_Q6, IRF_Q6, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION
GO Biological Process (1): positive regulation of canonical NF-kappaB signal transduction (GO:0043123)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| canonical NF-kappaB signal transduction | 1 |
| regulation of canonical NF-kappaB signal transduction | 1 |
| positive regulation of intracellular signal transduction | 1 |
| binding | 1 |
Protein interactions and networks
STRING
450 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LURAP1L | SLC4A3 | P48751 | 454 |
| LURAP1L | UBE2G1 | P62253 | 440 |
| LURAP1L | HYCC2 | Q8IXS8 | 405 |
| LURAP1L | C10orf67 | Q8IYJ2 | 394 |
| LURAP1L | WSCD2 | Q2TBF2 | 380 |
| LURAP1L | ERICH6B | Q5W0A0 | 372 |
| LURAP1L | ADGRL2 | O95490 | 371 |
| LURAP1L | FRMD7 | Q6ZUT3 | 367 |
| LURAP1L | REELD1 | A0A1B0GV85 | 359 |
| LURAP1L | ADGRL3 | Q9HAR2 | 352 |
| LURAP1L | KRTAP4-5 | Q9BYR2 | 348 |
| LURAP1L | CDH20 | Q9HBT6 | 340 |
| LURAP1L | WDR37 | Q9Y2I8 | 336 |
| LURAP1L | CACNA2D1 | P54289 | 335 |
| LURAP1L | AVL9 | Q8NBF6 | 327 |
IntAct
24 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LURAP1L | PATZ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM161A | LURAP1L | psi-mi:“MI:0915”(physical association) | 0.560 |
| LURAP1L | TBCCD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LURAP1L | ATPAF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDCBP | LURAP1L | psi-mi:“MI:0915”(physical association) | 0.560 |
| LURAP1L | PRPH | psi-mi:“MI:0915”(physical association) | 0.560 |
| CFTR | LURAP1L | psi-mi:“MI:0915”(physical association) | 0.370 |
| NOD2 | LURAP1L | psi-mi:“MI:0915”(physical association) | 0.370 |
| LURAP1L | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| PATZ1 | LURAP1L | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAM161A | LURAP1L | psi-mi:“MI:0915”(physical association) | 0.000 |
| TBCCD1 | LURAP1L | psi-mi:“MI:0915”(physical association) | 0.000 |
| ATPAF2 | LURAP1L | psi-mi:“MI:0915”(physical association) | 0.000 |
| SDCBP | LURAP1L | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (36): KIAA1598 (Affinity Capture-MS), NEFM (Affinity Capture-MS), SNTB2 (Affinity Capture-MS), CDC42BPA (Affinity Capture-MS), CDC42BPB (Affinity Capture-MS), FBXO28 (Affinity Capture-MS), HSF1 (Affinity Capture-MS), SNAP29 (Affinity Capture-MS), TP53RK (Affinity Capture-MS), CDC42BPA (Affinity Capture-MS), CDC42BPB (Affinity Capture-MS), KIAA1598 (Affinity Capture-MS), FBXO28 (Affinity Capture-MS), HSF1 (Affinity Capture-MS), NEFM (Affinity Capture-MS)
ESM2 similar proteins: A1L168, A1L3T7, A6NGS2, A6QQF7, D4A8G3, O15049, P0C7N2, P0C7N4, P17257, P58660, Q08AY9, Q0V7M8, Q0VDN7, Q14BJ1, Q2NL23, Q3KP66, Q3LUD3, Q3UNU4, Q4LEZ3, Q566R4, Q571B6, Q5BJW5, Q5ND29, Q5RFZ7, Q5XIS1, Q6NSJ2, Q6P1G6, Q6Q0N2, Q7TN12, Q7TSI1, Q811W1, Q8BL43, Q8C7U1, Q8IV03, Q8K1S6, Q8K2P1, Q8N137, Q8N5H3, Q8TE77, Q8WWL2
Diamond homologs: D4A8G3, Q5BJW5, Q8IV03, Q8K2P1, Q96LR2, Q9D6I9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 70 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 916565 | NM_203403.2(LURAP1L):c.346C>T (p.Arg116Cys) | Likely pathogenic |
SpliceAI
602 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:12821383:TAG:T | acceptor_loss | 1.0000 |
| 9:12819140:GC:G | donor_gain | 0.9900 |
| 9:12821377:T:TA | acceptor_gain | 0.9900 |
| 9:12821384:A:AG | acceptor_gain | 0.9900 |
| 9:12821384:AG:A | acceptor_gain | 0.9900 |
| 9:12821385:G:GA | acceptor_gain | 0.9900 |
| 9:12821385:GG:G | acceptor_gain | 0.9900 |
| 9:12821385:GGTT:G | acceptor_gain | 0.9900 |
| 9:12821385:GGTTA:G | acceptor_gain | 0.9900 |
| 9:12775773:G:GG | donor_gain | 0.9800 |
| 9:12776024:GATG:G | donor_gain | 0.9800 |
| 9:12776025:ATGG:A | donor_loss | 0.9800 |
| 9:12776027:GGT:G | donor_loss | 0.9800 |
| 9:12776029:TGAG:T | donor_loss | 0.9800 |
| 9:12776030:G:GG | donor_loss | 0.9800 |
| 9:12821382:ATAG:A | acceptor_gain | 0.9800 |
| 9:12821383:T:G | acceptor_gain | 0.9800 |
| 9:12821385:GGT:G | acceptor_gain | 0.9800 |
| 9:12775824:G:T | donor_gain | 0.9700 |
| 9:12775825:A:T | donor_gain | 0.9700 |
| 9:12776028:G:GG | donor_gain | 0.9700 |
| 9:12821382:A:AG | acceptor_gain | 0.9700 |
| 9:12775298:G:T | donor_gain | 0.9500 |
| 9:12776031:A:AC | donor_loss | 0.9500 |
| 9:12819141:C:G | donor_gain | 0.9500 |
| 9:12819182:G:GG | donor_gain | 0.9500 |
| 9:12776019:C:T | donor_gain | 0.9400 |
| 9:12821381:CATAG:C | acceptor_gain | 0.9400 |
| 9:12775264:T:TA | donor_gain | 0.9300 |
| 9:12775265:A:AA | donor_gain | 0.9300 |
AlphaMissense
1507 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000002502 (9:12773396 T>A), RS1000036050 (9:12803791 A>G), RS1000062683 (9:12799011 C>G,T), RS1000115524 (9:12809861 T>A), RS1000141355 (9:12809514 C>G), RS1000176334 (9:12800061 C>T), RS1000277798 (9:12814970 T>C), RS1000356017 (9:12780652 C>T), RS1000438701 (9:12780829 T>C), RS1000468702 (9:12800353 T>C), RS1000491975 (9:12817387 A>C,G), RS1000509741 (9:12822476 G>A,C), RS1000557585 (9:12777824 G>A), RS1000564710 (9:12790350 G>A), RS1000575735 (9:12823540 A>G)
Disease associations
OMIM: gene MIM:616130 | disease phenotypes: MIM:189960
GenCC curated gene-disease
Mondo (1): esophageal atresia/tracheoesophageal fistula (MONDO:0008586)
Orphanet (1): Esophageal atresia (Orphanet:1199)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002126_14 | Periodontitis (CDC/AAP) | 1.000000e-06 |
| GCST003097_40 | Pediatric autoimmune diseases | 1.000000e-07 |
| GCST003263_105 | Post bronchodilator FEV1 in COPD | 4.000000e-06 |
| GCST003263_106 | Post bronchodilator FEV1 in COPD | 4.000000e-06 |
| GCST009391_396 | Metabolite levels | 9.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004314 | forced expiratory volume |
| EFO:0010437 | triacylglycerol 58:10 measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C531835 | Esophageal atresia with or without tracheoesophageal fistula (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
48 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | increases expression | 4 |
| Benzo(a)pyrene | increases expression | 3 |
| bisphenol A | affects expression, increases expression | 2 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Valproic Acid | decreases methylation, increases expression | 2 |
| Cadmium Chloride | decreases expression, increases expression | 2 |
| Particulate Matter | increases abundance, increases expression | 2 |
| trichostatin A | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| methylparaben | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| didecyldimethylammonium | increases expression | 1 |
| nickel sulfate | increases expression | 1 |
| 1-nitropyrene | increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| 2,2’,4,4’,5-brominated diphenyl ether | increases expression | 1 |
| abrine | increases expression | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | increases expression | 1 |
| NSC 689534 | affects binding, increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| NSC305787 | increases expression | 1 |
| NSC668394 | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Zoledronic Acid | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases methylation | 1 |
| Azathioprine | increases expression | 1 |
| Cannabidiol | increases expression | 1 |
| Copper | affects binding, increases expression | 1 |
Clinical trials (associated diseases)
5 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT03792360 | PHASE1 | WITHDRAWN | Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae |
| NCT02033772 | Not specified | COMPLETED | Prospective Data Collection of Patients < 6 Months of Age Undergoing Thoracoscopic Surgery |
| NCT02364843 | Not specified | TERMINATED | A Physiological Study to Determine the Enteral Threonine Requirements in Infants Aged 1 to 6 Months |
| NCT03455881 | Not specified | UNKNOWN | Phenotypic and Genetic Assessment of Tracheal and Esophageal Birth Defects in Patients |
| NCT03730454 | Not specified | ACTIVE_NOT_RECRUITING | Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): autoimmune disease, common variable immunodeficiency, esophageal atresia/tracheoesophageal fistula